Skip to main content
Screener/Healthcare/Biotechnology

VRTX — Vertex Pharmaceuticals Incorporated

NASDAQ
$512.49+4.10 (+0.81%)
Nasdaq 100S&P 500Large CapHealthcareHigh ROELow BetaMost Profitable
$374.17
$560.25
$501.01
$514.10
EPS (TTM)$16.86
P/E Ratio30.40
Dividend Yield—
Market Cap$131.05B
Volume515K
Prev Close$508.34
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$3.0B$1.0B$4.0286.8%34.5%
Q4 '25$3.2B$1.2B$4.6585.6%36.9%
Q3 '25$3.1B$1.1B$4.2086.5%35.2%
Q2 '25$3.0B$1.0B$3.9986.3%34.8%
Q1 '25$2.8B$646.3M$2.4986.9%23.3%
Q4 '24$2.9B$913.0M$3.5085.5%31.4%
Q3 '24$2.8B$1.0B$4.0185.8%37.7%
Q2 '24$2.6B-$3.6B$-13.9285.9%-135.8%
Get Your Daily Market Recap